Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial
S., Abdalla, A
Our Titan therapies are doctor prescribed & shipped directly to your doorstep from a licensed US pharmacy!
The combined use of the lysosome disrupting agent siramesine and the tyrosine kinase inhibitor lapatinib can induce the accumulation of intracellular iron ions by reducing the expression of ferroportin (FPN) and increasing the expression of TF, and induces MDA MB 231, MCF-7, ZR -75 and SKBr3 breast cancer cells undergo ferroptosis, which provides a new strategy for the treatment of breast cancer [113]
10.1016/j.cmet.2011.08.016 Cell Metab
Chalmers RA, Bain MD, Michelakakis H, et al